Lupus nephritis: induction therapy.

about

Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis

P2860

Q21195423-ADA05245-3741-4FD4-82F0-144F2F0803B4

P2860

Lupus nephritis: induction therapy.

Item

http://www.wikidata.org/entity/Q36085856

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Lupus nephritis: induction therapy.

@ast

Lupus nephritis: induction therapy.

@en

type

Item

label

Lupus nephritis: induction therapy.

@ast

Lupus nephritis: induction therapy.

@en

prefLabel

Lupus nephritis: induction therapy.

@ast

Lupus nephritis: induction therapy.

@en

P1476

Lupus nephritis: induction therapy.

@en

P2093

T M Chan

http://www.w3.org/2001/XMLSchema#string

P2860

Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis.

Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide.

Management of lupus nephritis: an update.

Prognostic factors in lupus nephritis. Contribution of renal histologic data.

Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies.

Treatment of diffuse proliferative lupus nephritis with prednisone and combined prednisone and cyclophosphamide.

Immunosuppressive therapy in high-risk transplant patients: dose-dependent efficacy of mycophenolate mofetil in African-American renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.

Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups.

Treatment of diffuse proliferative lupus glomerulonephritis: a comparison of two cyclophosphamide-containing regimens.

Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.

P304

s27-32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1191/0961203305LU2114OA

http://www.w3.org/2001/XMLSchema#string

P478

14 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15803928

http://www.w3.org/2001/XMLSchema#string

Lupus nephritis: induction therapy.

about

P2860

P2860

Lupus nephritis: induction therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698